Psoriasis health impacts and complications

Recent medical research and clinical findings highlight the diverse systemic and psychological impacts of psoriasis. Studies indicate a significant link between the condition and erectile dysfunction, suggesting that systemic inflammation may damage the endothelium and impair blood flow. Furthermore, comorbid conditions such as type 2 diabetes, high blood pressure, and obesity are noted as contributing factors to sexual dysfunction. Genital psoriasis specifically can impact intimacy due to physical discomfort, such as itching and soreness.

Clinical analyses presented at the 2026 Fall Clinical Dermatology Conference suggest that the steroid-free cream and foam ZORYVE (roflumilast) may mitigate these issues. In phase 3 trials, including the DERMIS and ARRECTOR studies, patients reported a reduction in sexual difficulties and relationship problems compared to a placebo, with many patients experiencing meaningful relief from itching.

Beyond physical and sexual health, psoriasis is linked to high rates of mental health challenges. Research published by the Journal of the European Academy of Dermatology and Venereology indicates that depression can affect up to 62% of individuals living with the disease. The condition is associated with broader quality-of-life issues, including impacts on social participation and personal relationships, with women facing specific challenges related to stress and loneliness.

Systemic risks also include an increased likelihood of developing psoriatic arthritis, which affects approximately one third of patients. Persistent inflammation is further linked to cardiovascular and metabolic complications, such as abnormal cholesterol and triglyceride levels. Globally, an estimated 100 million people live with psoriasis.